Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea · Delayed Price · Currency is KRW 5,710.00
-20.00 (-0.35%)
At close: Oct 31, 2025
Kwang Dong Pharmaceutical Revenue
Kwang Dong Pharmaceutical had revenue of 425.29B KRW in the quarter ending June 30, 2025, with 3.02% growth. This brings the company's revenue in the last twelve months to 1.62T, up 0.68% year-over-year. In the year 2024, Kwang Dong Pharmaceutical had annual revenue of 1.64T with 8.34% growth.
Revenue (ttm)
1.62T
Revenue Growth
+0.68%
P/S Ratio
0.14
Revenue / Employee
1.59B
Employees
1,021
Market Cap
224.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.64T | 126.26B | 8.34% |
| Dec 31, 2023 | 1.51T | 82.91B | 5.79% |
| Dec 31, 2022 | 1.43T | 93.36B | 6.98% |
| Dec 31, 2021 | 1.34T | 94.41B | 7.59% |
| Dec 31, 2020 | 1.24T | 5.51B | 0.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CJ Cheiljedang | 29.35T |
| LOTTE | 15.54T |
| Dongwon Industries | 9.24T |
| LG H&H | 6.63T |
| KT&G Corporation | 6.23T |
| Amorepacific | 4.14T |
| Nongshim | 3.47T |
| ORION | 3.22T |